Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Health beliefs and physical activity behavior in adults with multiple sclerosis.
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.
The Choroid Plexus in Healthy and Diseased Brain.
Teriflunomide for oral therapy in multiple sclerosis.
The epidemiology and pathophysiology of neurogenic bladder.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β.
Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring.
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Pages
« first
‹ previous
…
294
295
296
297
298
299
300
301
302
…
next ›
last »